Answers are grounded in this paper and cite their sources.
Research shows soluble factors from synoviocytes contribute to IL-6 production in JIA, suggesting new treatment targets.
Our findings suggest factors secreted by ETB FLS including IL-6 protein may contribute to disease extension. These data highlight the potential role of early synovial signaling in shaping disease trajectory and support further investigation into IL-6 and FLS as possible therapeutic targets to prevent progression.
No takes yet. Share an insight, caveat, or question.
Simonds et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: